We are excited to announce that Kava, one of the largest DeFi lending platforms on Cosmos, has strategically partnered with Injective Protocol. In doing so, Kava is bringing its rapidly growing lending facility to our innovative layer-2 decentralized derivatives exchange, unlocking a host of new possibilities to traders globally.
Given that we currently provide an entirely open-source exchange infrastructure, Kava’s assets can now be used in a variety of new functions not possible before on other platforms. This will help expand the use cases of Kava’s lending facility while simultaneously allowing users of Injective DEX to trade new asset types and interact with new DeFi networks given Injective’s unique cross-chain capabilities.
As members of the Binance ecosystem, the teams at Kava and Injective have aligned closely on a variety of exciting challenges in DeFi. Over the months we have been increasingly impressed by their development efforts and high levels of adoption with respect to decentralized lending. We have come to share a common vision regarding the expansion and accessibility of DeFi use.
Since both Injective and Kava are built with the Cosmos SDK, we will be able to seamlessly integrate with one another via Inter-Blockchain Communication (IBC). Our current plan is to leverage the IBC protocol to connect with Kava to solve cross-chain interactions effectively as well as use the interoperability to increase the use cases of Kava via our decentralized derivatives.
The integration will also enable Kava and Injective Protocol to exchange Chainlink oracle data, services, as well as on-chain and off-chain resources that will help increase our derivative offerings further. The goal is to also enable new types of synthetic assets and novel derivative products to be traded on our DEX with the help of Kava.
Kava CEO Brain Kerr has been a strong proponent of Injective for some time and had this to say when asked about our new partnership:
“It’s wonderful to have the opportunity to collaborate with a fellow Binance ecosystem project in the area of DeFi. Injective Protocol is furthering the DEX and derivative trading experience in a decentralized fashion while addressing issues such as front-running. Kava’s lending facility, USDX stable coin, and other financial services will enable Injective Protocol to deliver even better experiences to their users.”
Kava will be a great addition to our exchange as we continue to delve into new forms of decentralized derivatives markets and further explore cross-chain yield generation. Both the Kava and Injective Protocol teams will work together closely in the long-run to facilitate the mass adoption of DeFi.
About Injective Protocol
Injective Protocol is the first layer-2 decentralized exchange protocol that unlocks the full potential of decentralized derivatives and borderless DeFi. Injective Protocol enables fully decentralized trading without any restrictions, allowing individuals to trade on any derivative market of their choosing. Injective Protocol is backed by a prominent group of stakeholders including Pantera Capital, one of the most renowned venture capital firms in the world, and the leading cryptocurrency exchange, Binance.
Want to learn more about Injective? Join us via the channels below!